STTCOMP RCE FA LONG RECCE Pharmaceutical MC ~ $213m SP ~ 1.25c
Consolidated in a band between 90c and $1.30, with $1.30 my break point for a run to $1.70.
Fundamental news also helping interest and technical chart. Healthcare sector my favourite area for investment at present.
Recce Pharmaceuticals Ltd (RCE) is a drug discovery and development business commercialising a new class of synthetic antibiotics with broad spectrum activity designed to address the global health challenge of antibiotic resistant superbugs. Its patented lead candidate known as RECCE 327 has been developed for the treatment of blood infections and sepsis derived from E. coli and S. aureus bacteria - including their superbug forms.
